VCP
INO icon

Verus Capital Partners’s Inovio Pharmaceuticals INO Stock Holding History

Verus Capital Partners’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$4K Buy
+50
New +$3.08K ﹤0.01% 1228

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Verus Capital Partners's INO Position: Q1 2020 in Review

Verus Capital Partners opened a new position in Inovio Pharmaceuticals (INO) in Q1 2020: 50 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings.

158 funds tracked by Wall St. Rank hold INO as of Q1 2020.

  • Verus Capital Partners held 50 shares of Inovio Pharmaceuticals worth $4K as of Q1 2020.
  • Inovio Pharmaceuticals was a new Verus Capital Partners position in Q1 2020.
  • Inovio Pharmaceuticals made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1228 holding.
  • 158 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.